Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | S-equol |
| Synonyms | |
| Therapy Description |
S-equol is a plant-derived estrogen receptor agonist, which may decrease tumor cell growth (PMID: 21790611, PMID: 24487643, PMID: 31623342, PMID: 31956333). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| S-equol | Equol | S-equol is a plant-derived estrogen receptor agonist, which may decrease tumor cell growth (PMID: 21790611, PMID: 24487643, PMID: 31623342, PMID: 31956333). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT02352025 | Phase I | S-equol | S-equol in Women With Triple Negative Breast Cancer | Completed | USA | 0 |